The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Akari Therapeutics, Plc(NASDAQ:AKTX)

Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of treatments for a range of rare and orphan autoimmune and inflammatory diseases. Its lead product candidate is Coversin, a second-generation complement inhibitor that is in Phase I...
Akari Therapeutics Plc Op Cashflow Per Share ttm
Akari Therapeutics Plc Free Cashflow Per Share ttm
Akari Therapeutics Plc Cash Per Share ttm
Akari Therapeutics Plc (GAAP) P/E ratio ttm
Akari Therapeutics Plc P/B ratio ttm
No extra charts and metrics for this ticker.